Inventor
BRUNCKO MILAN
US44 patents
⚠️ This page may combine multiple inventors who share the name “BRUNCKO MILAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
18 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US8686136B2Apr 1, 2014
Apoptosis promoters
ABBVIE INC20 citations92
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US8940737B2Jan 27, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC7 citations83
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US11786519B2Oct 17, 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9844547B2Dec 19, 2017
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations62
US9266877B2Feb 23, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US9227963B2Jan 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US8889675B2Nov 18, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC3 citations62
US11633497B2Apr 25, 2023
Anti-c-Met antibody drug conjugates
ABBVIE INC1 citations59
US9650358B2May 16, 2017
Pyridine CDK9 kinase inhibitors
ABBVIE INC1 citations52
US9359296B2Jun 7, 2016
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9035047B2May 19, 2015
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9877958B2Jan 30, 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC1 citations51
US9796708B2Oct 24, 2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors
ABBVIE INC0 citations36
ABBOTT LAB
17 patentsUS7390799B2Jun 24, 2008
Apoptosis promoters
ABBOTT LAB331 citations98
US8354404B2Jan 15, 2013
Apoptosis promoters
ABBOTT LAB39 citations97
US7973161B2Jul 5, 2011
Apoptosis promoters
ABBOTT LAB70 citations97
US7767684B2Aug 3, 2010
Apoptosis promoters
ABBOTT LAB107 citations97
US7709467B2May 4, 2010
Apoptosis promoters
ABBOTT LAB50 citations97
US7642260B2Jan 5, 2010
Apoptosis promoters
ABBOTT LAB82 citations97
US7504512B2Mar 17, 2009
N-acylsulfonamide apoptosis promoters
ABBOTT LAB58 citations97
US6720338B2Apr 13, 2004
N-acylsulfonamide apoptosis promoters
ABBOTT LAB98 citations97
US7585858B2Sep 8, 2009
N-sulfonylcarboximidamide apoptosis promoters
ABBOTT LAB19 citations93
US7906505B2Mar 15, 2011
Apoptosis promoters
ABBOTT LAB18 citations92
US7754886B2Jul 13, 2010
N-acylsulfonamide apoptosis promoters
ABBOTT LAB34 citations90
US7981888B2Jul 19, 2011
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
ABBOTT LAB8 citations84
US5955440ASep 21, 1999
Macrolide LHRH antagonists
ABBOTT LAB19 citations82
US5981521ANov 9, 1999
Tetrahydroisoquinoline derivatives as LHRH antagonists
ABBOTT LAB11 citations72
US6387885B1May 14, 2002
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
ABBOTT LAB4 citations60
US5972898AOct 26, 1999
3',3-N-bis-substituted macrolide LHRH antagonists
ABBOTT LAB4 citations60
US6495562B1Dec 17, 2002
Naphthamidine urokinase inhibitors
ABBOTT LAB5 citations56
BRUNCKO MILAN
6 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97
US8173811B2May 8, 2012
Apoptosis promoters
BRUNCKO MILAN50 citations97
US8084607B2Dec 27, 2011
Apoptosis promoters
BRUNCKO MILAN43 citations93
US8614318B2Dec 24, 2013
Apoptosis promoters
BRUNCKO MILAN37 citations92